Cargando…

Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report

RATIONALE: A hormone-active metastatic Hürthle cell thyroid carcinoma (HCTC) and Graves disease (GD) present a therapeutic challenge and is rarely reported. PATIENT CONCERNS: We present a 64-year-old male patient, who had dyspnea and left hip pain lasting 4 months. He had clinical signs of hyperthyr...

Descripción completa

Detalles Bibliográficos
Autores principales: Besic, Nikola, Vidergar-Kralj, Barbara, Zaletel, Katja, Grasic-Kuhar, Cvetka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238273/
https://www.ncbi.nlm.nih.gov/pubmed/34160415
http://dx.doi.org/10.1097/MD.0000000000026384
_version_ 1783714869853290496
author Besic, Nikola
Vidergar-Kralj, Barbara
Zaletel, Katja
Grasic-Kuhar, Cvetka
author_facet Besic, Nikola
Vidergar-Kralj, Barbara
Zaletel, Katja
Grasic-Kuhar, Cvetka
author_sort Besic, Nikola
collection PubMed
description RATIONALE: A hormone-active metastatic Hürthle cell thyroid carcinoma (HCTC) and Graves disease (GD) present a therapeutic challenge and is rarely reported. PATIENT CONCERNS: We present a 64-year-old male patient, who had dyspnea and left hip pain lasting 4 months. He had clinical signs of hyperthyroidism and a tumor measuring 9 cm in diameter of the left thyroid lobe, metastatic neck lymph node and metastases in the lungs, mediastinum, and bones. DIAGNOSIS: Laboratory findings confirmed hyperthyroidism and GD. Fine-needle aspiration biopsy and cytological investigation revealed metastases of HCTC in the skull and in the 8th right rib. A CT examination showed a thyroid tumor, metastatic neck lymph node, metastases in the lungs, mediastinum and in the 8th right rib measuring 20 × 5.6 × 4.5 cm, in the left acetabulum measuring 9 × 9 × 3 cm and parietooccipitally in the skull measuring 5 × 4 × 2 cm. Histology after total thyroidectomy and resection of the 8th right rib confirmed metastatic HCTC. INTERVENTIONS: The region of the left hip had been irradiated with concomitant doxorubicin 20 mg once weekly. When hyperthyroidism was controlled with thiamazole, a total thyroidectomy was performed. Persistent T3 hyperthyroidism, most likely caused by TSH-R-stimulated T3 production in large metastasis in the 8th right rib, was eliminated by rib resection. Thereafter, the patient was treated with 3 radioactive iodine-131 (RAI) therapies (cumulative dose of 515 mCi). Unfortunately, the tumor rapidly progressed after treatment with RAI and progressed 10 months after therapy with sorafenib. OUTCOMES: Despite treatment, the disease rapidly progressed and patient died due to distant metastases. He survived for 28 months from diagnosis. LESSONS: Simultaneous hormone-active HCTC and GD is extremely rare and prognosis is dismal. Concomitant external beam radiotherapy and doxorubicin chemotherapy, followed by RAI therapy, prevented the growth of a large metastasis in the left hip in our patient. However, a large metastasis in the 8th right rib presented an unresolved problem. Treatment with rib resection and RAI did not prevent tumor recurrence. External beam radiotherapy and sorafenib treatment failed to prevent tumor growth.
format Online
Article
Text
id pubmed-8238273
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-82382732021-07-06 Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report Besic, Nikola Vidergar-Kralj, Barbara Zaletel, Katja Grasic-Kuhar, Cvetka Medicine (Baltimore) 4300 RATIONALE: A hormone-active metastatic Hürthle cell thyroid carcinoma (HCTC) and Graves disease (GD) present a therapeutic challenge and is rarely reported. PATIENT CONCERNS: We present a 64-year-old male patient, who had dyspnea and left hip pain lasting 4 months. He had clinical signs of hyperthyroidism and a tumor measuring 9 cm in diameter of the left thyroid lobe, metastatic neck lymph node and metastases in the lungs, mediastinum, and bones. DIAGNOSIS: Laboratory findings confirmed hyperthyroidism and GD. Fine-needle aspiration biopsy and cytological investigation revealed metastases of HCTC in the skull and in the 8th right rib. A CT examination showed a thyroid tumor, metastatic neck lymph node, metastases in the lungs, mediastinum and in the 8th right rib measuring 20 × 5.6 × 4.5 cm, in the left acetabulum measuring 9 × 9 × 3 cm and parietooccipitally in the skull measuring 5 × 4 × 2 cm. Histology after total thyroidectomy and resection of the 8th right rib confirmed metastatic HCTC. INTERVENTIONS: The region of the left hip had been irradiated with concomitant doxorubicin 20 mg once weekly. When hyperthyroidism was controlled with thiamazole, a total thyroidectomy was performed. Persistent T3 hyperthyroidism, most likely caused by TSH-R-stimulated T3 production in large metastasis in the 8th right rib, was eliminated by rib resection. Thereafter, the patient was treated with 3 radioactive iodine-131 (RAI) therapies (cumulative dose of 515 mCi). Unfortunately, the tumor rapidly progressed after treatment with RAI and progressed 10 months after therapy with sorafenib. OUTCOMES: Despite treatment, the disease rapidly progressed and patient died due to distant metastases. He survived for 28 months from diagnosis. LESSONS: Simultaneous hormone-active HCTC and GD is extremely rare and prognosis is dismal. Concomitant external beam radiotherapy and doxorubicin chemotherapy, followed by RAI therapy, prevented the growth of a large metastasis in the left hip in our patient. However, a large metastasis in the 8th right rib presented an unresolved problem. Treatment with rib resection and RAI did not prevent tumor recurrence. External beam radiotherapy and sorafenib treatment failed to prevent tumor growth. Lippincott Williams & Wilkins 2021-06-25 /pmc/articles/PMC8238273/ /pubmed/34160415 http://dx.doi.org/10.1097/MD.0000000000026384 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 4300
Besic, Nikola
Vidergar-Kralj, Barbara
Zaletel, Katja
Grasic-Kuhar, Cvetka
Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report
title Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report
title_full Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report
title_fullStr Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report
title_full_unstemmed Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report
title_short Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report
title_sort graves disease and metastatic hormonal-active hürthle cell thyroid cancer: a case report
topic 4300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238273/
https://www.ncbi.nlm.nih.gov/pubmed/34160415
http://dx.doi.org/10.1097/MD.0000000000026384
work_keys_str_mv AT besicnikola gravesdiseaseandmetastatichormonalactivehurthlecellthyroidcanceracasereport
AT vidergarkraljbarbara gravesdiseaseandmetastatichormonalactivehurthlecellthyroidcanceracasereport
AT zaletelkatja gravesdiseaseandmetastatichormonalactivehurthlecellthyroidcanceracasereport
AT grasickuharcvetka gravesdiseaseandmetastatichormonalactivehurthlecellthyroidcanceracasereport